EUVIMEDEUVIMED entdecken
Crossref

An Optimized Droplet Digital PCR Assay for HER2 Copy Number Variation in Breast Cancer Based on Multi-reference Genes

Jinbing Xue, Houshi Ma, Xiaoliang Zhang, Shun Wang, Jinxian Wang, Zeqin Li, Xi Wu, Tianhang Yang, Changsong Zhang, Gangyin Luo

Applied Biochemistry and Biotechnology · 2025

DOI: 10.1007/s12010-025-05233-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2025. Verfasst von Jinbing Xue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, DNA Copy Number Variations, Polymerase Chain Reaction. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Suzhou Key Technology (Research) Project of Critical and Infectious Diseases Precaution and Control, Strategic Priority Research Program of the Chinese Academy of Sciences, Science and Technology Program of Suzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted therapy is essential for the 15-30% invasive breast cancer patients with human epidermal growth factor receptor 2 (HER2) over-expression. However, current HER2 diagnosing methods rely on complex manual works and highly subjective interpretations. To more accurately and objectively assess the HER2 amplification status of formalin fixed paraffin embedded (FFPE) samples, a droplet digital PCR (ddPCR) assay based on multi-reference genes was developed. We established a four-fluorescence ddPCR assay using breast cancer cell lines (T-47D and SK-BR-3) and validated it on 101 clinical breast cancer FFPE samples. Compared to clinicopathological results, the ddPCR assay based on two out of three reference genes demonstrated superior sensitivity (82.6%), specificity (98.7%), and consistency (95.0%) in determining HER2 status over assays using single or three reference genes. Whole genome sequencing of the abnormal cases further confirmed that the ddPCR assay outperformed clinical immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and quantitative PCR (qPCR) in accuracy. Our findings demonstrate that the multi-reference gene ddPCR assay significantly improves the accuracy of HER2 status detection and reduces errors associated with chromosome 17 abnormalities. This method holds promise as a complementary or alternative approach to conventional IHC and FISH testing in tissue biopsies and is also feasible for liquid biopsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesDNA Copy Number VariationsPolymerase Chain ReactionHumansFemaleCell Line, TumorIn Situ Hybridization, Fluorescence

Stichwörter der Autor:innen

Breast cancerDdPCRHER2Multi-reference genes

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China.
  • Suzhou ZhongKe Medical Device Industry Development Co., Ltd, Suzhou, 215163, China.
  • Department of Geriatrics, The General Hospital of Western Theater Command, Chengdu, 610083, China.
  • Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China. yangth@sibet.ac.cn.
  • Jinan Guoke Medical Technology Development Co., Ltd, Jinan, 250013, China. yangth@sibet.ac.cn.
  • Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. zhangchangsong@suda.edu.cn.

Förderung

  • Suzhou Key Technology (Research) Project of Critical and Infectious Diseases Precaution and Control
  • Strategic Priority Research Program of the Chinese Academy of Sciences
  • Science and Technology Program of Suzhou
  • Suzhou Pilot Project of Basic Research
  • Suzhou Municipal Commission of Health and Family Planning
  • Suzhou New District Science and Technology Program
  • Youth Project of Natural Science Foundation of Shandong Province

Zitieren

APA

Xue, J., Ma, H., Zhang, X., Wang, S., Wang, J., Li, Z., Wu, X., Yang, T., Zhang, C., & Luo, G. (2025). An Optimized Droplet Digital PCR Assay for HER2 Copy Number Variation in Breast Cancer Based on Multi-reference Genes. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-025-05233-0

Vancouver

Xue J, Ma H, Zhang X, Wang S, Wang J, Li Z, et al. An Optimized Droplet Digital PCR Assay for HER2 Copy Number Variation in Breast Cancer Based on Multi-reference Genes. Applied Biochemistry and Biotechnology. 2025. doi:10.1007/s12010-025-05233-0

BibTeX
@article{Xue2025,
  author = {Xue, Jinbing and Ma, Houshi and Zhang, Xiaoliang and Wang, Shun and Wang, Jinxian and Li, Zeqin and Wu, Xi and Yang, Tianhang and Zhang, Changsong and Luo, Gangyin},
  title = {An Optimized Droplet Digital PCR Assay for HER2 Copy Number Variation in Breast Cancer Based on Multi-reference Genes},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2025},
  doi = {10.1007/s12010-025-05233-0}
}
Kostenlos starten →